Infographic Zero-Cost Preventative Care for Californians & Extended Coverage for STI Screenings September 10, 2023 Employer coverage for PrEP is at risk—proposed legislation in California seeks to preserve and extend coverage for PrEP and other preventative care. Learn more about the Texas case Braidwood Management v. Becerra and what California Assembly Bill 1645 will do to address […]
Policy Brief Are California pharmacists ready to provide long-acting injectable pre- exposure prophylaxis (PrEP) for HIV prevention? July 31, 2023 A new CHPRC analysis finds strong potential to increase access to long-acting injectable forms of HIV prevention in California pharmacies. Pharmacists surveyed were highly supportive of pharmacy-based PrEP provision under Senate Bill 159, and more […]
Policy Brief People Living With HIV who Smoke Face Barriers to Accessing Smoking Cessation Services in Southern California HIV Safety Nets May 15, 2023 A new study from the California HIV/AIDS Policy Research Centers finds that less than 30% of safety net providers in the Ryan White HIV/AIDS Program in Southern California offered smoking cessation […]
Policy Brief Senate Bill 159 Implementation California Pharmacists’ Perspectives on Opportunities and Challenges March 7, 2023 A new study from the California HIV/AIDS Policy Research Centers, in collaboration with the Center on Reproductive Health, Law, and Policy, Birth Control Pharmacist, and the California Society of Health-System Pharmacists, finds that more than 90% of California pharmacists […]
Manuscript The Impact of Mental Health Conditions on Public Insurance Costs of Treating HIV/ AIDS January 31, 2023 Medicare and Medicaid insurance claims data for Californians living with HIV are analyzed in order to determine: (1)The prevalence of treatment for particular mental health diagnoses among people living with HIV (PLWH) with Medicare or Medicaid insurance in […]
Policy Brief The Use of HIV Over-the Counter (OTC) test in California from April to September 2013 January 3, 2023 Approval in mid-2012 of a consumer-controlled OTC HIV test by the Food and Drug Administration (FDA), which is responsible for drug and medical device approval for sales to the public, has made real the possibility […]
Full Report Addressing mpox disparities among MSM in Los Angeles County December 22, 2022 In the ongoing mpox (monkeypox) outbreak of 2022, California is the state with the highest number of cases and Los Angeles County (LAC) has the highest number of reported cases in the state. As of December 9, 2022, 2,245 confirmed mpox […]
Full Report A Decade of PrEP: Overcoming Access Barriers in the U.S. Through Expanded Delivery December 22, 2022 A decade after the FDA approved PrEP for HIV prevention, PrEP is still not accessible to all Americans who might benefit from this HIV prevention strategy. In this policy brief, we describe opportunities for expanded PrEP access. […]
Policy Brief Climate Change and Continuity of Care: Maintaining Access to Prevention and Care Services during Climate-Related Events in California June 1, 2022 Natural disasters related to climate change are on the rise in California, but the impacts of climate-related events on healthcare delivery and client engagement in care are not well understood. The critical […]
Infographic Addressing MPOX Disparities Among MSM in Los Angeles County May 15, 2022 In response to the 2022 mpox (monkeypox) outbreak, collaborators from the Southern California HIV/AIDS Policy Research Center and the University of Southern California adapted a validated microsimulation model to understand the dynamics of mpox disease transmission. Results estimate the impact of vaccination, treatment, […]
